# The Role of IGRA in Screening and Monitoring for TB During Anti TNF Therapy in Patients With IMID

> **NCT02135289** · — · COMPLETED · sponsor: **Chinese University of Hong Kong** · enrollment: 9160 (actual)

## Conditions studied

- Inflammatory Bowel Disease
- Crohn Disease
- Ulcerative Colitis
- Tuberculosis
- Immune-mediated Inflammatory Disease

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02135289
- **Lead sponsor:** Chinese University of Hong Kong
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2012-03
- **Primary completion:** 2019-07-31
- **Final completion:** 2019-07-31
- **Target enrollment:** 9160 (ACTUAL)
- **Last updated:** 2020-04-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02135289

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02135289, "The Role of IGRA in Screening and Monitoring for TB During Anti TNF Therapy in Patients With IMID". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02135289. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*